Stage IV Breast Cancer
Conditions
Brief summary
This randomized trial studies how well a mindfulness-based stress reduction program helps participants with breast cancer that has spread to other places in the body. A cancer diagnosis is a life-changing and highly stressful event for most people, often resulting in marked declines in quality of life both during and after treatment. There are approximately 3 million women living with a history of invasive breast cancer in the U.S., with at least 150,000 living with metastatic disease. Patient preferences suggest a high need for complementary and alternative medicine interventions to address these chronic symptoms. Mindfulness-based stress reduction programs may help women living with metastatic breast cancer manage symptoms related to cancer treatment and improve quality of life.
Detailed description
PRIMARY OBJECTIVES: I. To develop a novel online mindfulness-based stress reduction (MBSR) treatment for distressed metastatic breast cancer patients in the hope of reaching patients otherwise unable to participate in traditional interventions due to high symptom burden. II. Determine the impact of the intervention on both patient self-report and biological symptom measures. OUTLINE: Participants are randomized to 1 of 2 arms. INTERVENTION ARM: Participants receive online group sessions over 60 minutes for 6 weeks, including 15 minutes of practice on that session's topic and daily meditation or yoga for 45 minutes. At the conclusion of the study period participants participate in mindfulness meditation over 3 hours. Participants also receive a content manual and relaxation compact disc (CD). CONTROL ARM: Participants randomized to the wait-list control condition complete the online intervention as in the intervention arm after the initial 6-week period has ended.
Interventions
OTHERLaboratory Biomarker Analysis
Correlative studies
BEHAVIORALMeditation-Based Stress Reduction Program
Participate in 6-week online program
OTHERQuality-of-Life Assessment
Ancillary studies
OTHERQuestionnaire Administration
Ancillary studies
Sponsors
Roswell Park Cancer Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* A diagnosis of metastatic breast cancer within the past 5 years and treated at Roswell Park Cancer Institute (RPCI) * Ability to read and understand English * Current distress score of 4+ on the National Comprehensive Cancer Network (NCCN) distress thermometer * Access to an Internet connection with own device (computer, tablet, smartphone, etc.) * Patient not currently involved in an ongoing psychological intervention * If taking prescribed medication for mood or anxiety disorder, dosage has been consistent for prior 3 months
Exclusion criteria
* Unable to speak and understand English * Prior or current experience with mindfulness-based practice * Diagnosis of a psychotic disorder, bipolar disorder, substance abuse disorder, or reported suicidality * Current involvement in any other psychological treatment (excluding medication) during study duration * Currently being treated for another cancer diagnosis other than metastatic breast cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of the online intervention for metastatic breast cancer patients | At 6 weeks | Successfully completing 4 out of 6 week sessions of online intervention for distressed metastatic breast cancer patients. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in anxiety as measured by BSI-18 | Baseline and 6 weeks | Self reported screening inventory designed to assess participants level of anxiety. |
| Improvement in fatigue measured with the Functional Assessment of Cancer Therapy Fatigue questionnaire | Baseline and 6 weeks | Measured using the Functional Assessment of Cancer Therapy Fatigue (FACT-Fatigue). A questionnaire assessing fatigue. |
| Improvement in sleep impairment as measured by General Sleep Disturbance Scale | Baseline and 6 weeks | Measured using the General Sleep Disturbance Scale - A 21 item scale rating specific sleep problems from 0 (not at all) to 7 (every day) used to evaluate sleep disturbance |
| Improvement in pain | Baseline and 6 weeks | Visual analog scales will be used to assess multiple pain dimensions per the National Comprehensive Cancer Network (NCCN) guidelines for adult cancer pain. |
| Improvement in depression as measured by the Brief Symptom Inventory (BSI-18) | Baseline and 6 weeks | BSI-18 - a self reported screening inventory to detect states of depression, anxiety and emotional distress. |
| Improvement in blood pressure | Baseline and 6 weeks | Blood pressure will be taken twice at each of the study time-points to ensure an accurate reading. All outcome measures are treated as quantitative variables and will be summarized by cohort and time-point using the appropriate descriptive statistics. Comparisons made between the baseline and post-intervention assessment (6-week) will utilize one-sided permutation paired t-tests; with bootstrap or non-parametric methods considered as appropriate. |
| Improvement in cancer-related biomarkers | Baseline and 6 weeks | A panel of 25 cytokines reflecting Th1, Th2, and Th17 immunity will be collected, including (GMCSF, IFN-v, IL-1f3, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17A, IL-17F, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-27, IL-28A, IL-31, IL-33, MIP-3a/CCL20, TNFa, TNF\|3). To visualize the pattern of immunologic markers that jointly distinguish intervention arms, hypothesis |
| Increases in mindfulness | Baseline and 6 weeks | This will be measured with the Five Facet Mindfulness Questionnaire - (FFMQ). A questionnaire to explore mindfulness. |
| Improvement in quality of life (QOL): FACT-B | Baseline 6 weeks | This will be measured with the Functional Assessment of Cancer Comparisons made between the baseline and post-intervention assessment (6-week) will utilize one-sided permutation paired t-tests; with bootstrap or non-parametric methods considered as appropriate. |
Countries
United States
Outcome results
None listed